Demographic and clinical dataa
| Clinical parameters . | . |
|---|---|
| Gender | 8 females, 16 males |
| Age (yr) | 66.9 ± 8.5 |
| Smoking status | |
| Current smoker | 6 [25] |
| Ex-smoker | 16 [67] |
| Nonsmoker | 2 [8] |
| Smoking—pack-yr | 14.4 ± 8.6 |
| Histology | |
| Squamous cell | 9 [37.5] |
| Adenocarcinoma | 13 [54.2] |
| Large cell | 2 [8.3] |
| Grade | |
| Well | 16 [66.7] |
| Poor | 8 [33.3] |
| Stage | |
| IA | 8 [33.3] |
| IB | 10 [41.7] |
| IIB | 4 [16.7] |
| IIIA | 1 [4.2] |
| IIIB | 1 [4.2] |
| Presence of emphysema | 7 [29.2] |
| FEV1 (L)b | 2.44 ± 0.74 |
| FEV1 (% predicted) | 83.1 ± 24.6 |
| FVC (L) | 3.73 ± 0.94 |
| FVC (% predicted) | 93.6 ± 14.6 |
| Types of lung resections | |
| Pneumonectomy | 20 [83.3] |
| Lobectomy | 4 [16.7] |
| Postoperative treatment | |
| Radiotherapy | 7 [29.2] |
| Chemotherapy | 3 [12.5] |
| Clinical parameters . | . |
|---|---|
| Gender | 8 females, 16 males |
| Age (yr) | 66.9 ± 8.5 |
| Smoking status | |
| Current smoker | 6 [25] |
| Ex-smoker | 16 [67] |
| Nonsmoker | 2 [8] |
| Smoking—pack-yr | 14.4 ± 8.6 |
| Histology | |
| Squamous cell | 9 [37.5] |
| Adenocarcinoma | 13 [54.2] |
| Large cell | 2 [8.3] |
| Grade | |
| Well | 16 [66.7] |
| Poor | 8 [33.3] |
| Stage | |
| IA | 8 [33.3] |
| IB | 10 [41.7] |
| IIB | 4 [16.7] |
| IIIA | 1 [4.2] |
| IIIB | 1 [4.2] |
| Presence of emphysema | 7 [29.2] |
| FEV1 (L)b | 2.44 ± 0.74 |
| FEV1 (% predicted) | 83.1 ± 24.6 |
| FVC (L) | 3.73 ± 0.94 |
| FVC (% predicted) | 93.6 ± 14.6 |
| Types of lung resections | |
| Pneumonectomy | 20 [83.3] |
| Lobectomy | 4 [16.7] |
| Postoperative treatment | |
| Radiotherapy | 7 [29.2] |
| Chemotherapy | 3 [12.5] |